[ET Net News Agency, 14 January 2022] BRII-B (02137) fell 10.47% to HK$22.65.
It hits an intra-day low of HK$22.6, hitting an 1-month low, and an intra-day high of
HK$25.2. The total shares traded was 2.86 million, with a value of HK$67.17m. The active
buy/sell ratio is 43:57, with net selling turnover of HK$9.13m. CHINA INV INFO accounts
for greatest net responsive buying turnover of HK$5.2m, with volume weighted average price
of HK$23.379. MERRILL LYNCH FE accounts for greatest net responsive selling turnover of
HK$10.2m, with volume weighted average price of HK$23.499. The stock has fallen a combined
17.03% over the past 2 consecutive trading days.
The Hang Seng Index now fell 214 points, or 0.88% to 24,215; the Hang Seng China
Enterprises Index now fell 114 points, or 1.33% to 8,488; the Hang Seng TECH Index now
fell 100 points, or 1.74% to 5,695; with an overall turnover of HK$56.18b.
The SSE Composite Index now fell 22 points, or 0.64% to 3,532, with an overall turnover
of RMB252.61b.
The SZSE Component Index now rose 17 points, or 0.12% to 14,155, with an overall
turnover of RMB152.37b.
Basic Information
=================
----------------------------------
Nominal 22.650 % Chg -10.47%
High 25.200 Low 22.600
Shares Tr 2.86m Turnover 67.17m
10-D SMA 28.700 %H.V 89.572
20-D SMA 31.862 VWAP 23.459
50-D SMA 34.202 RSI14 29.577
----------------------------------
Status: Hitting an 1-month low, active buy/sell ratio is 43:57, with net selling turnover
of HK$9.13m, falling a combined 17.03% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
BRII-B (02137) 22.65 -10.47
GENSCRIPT BIO (01548) 30.90 -4.19
INNOVENT BIO (01801) 42.85 +0.23
JUNSHI BIO (01877) 49.60 +7.24
JXR (01951) 8.64 -1.03
WUXI BIO (02269) 91.55 +0.33
TIGERMED (03347) 96.30 +0.52
JOINN (06127) 61.50 -0.16
BEIGENE (06160) 141.70 -4.58
CANSINOBIO-B (06185) 168.60 +2.18
---------------------------------------------
(ed)